REFERENCES
- Perazella MA. Approach to patients with intradialytic hypotension: A focus on therapeutic options. Semin Dial. 1999; 12: 175–181
- Lin YF, Wang JY, Denq JC, Lin SH. Midodrine improves chronic hypotension in hemodialysis patients. Am J Med Sci. 2003; 325(5)256–261
- Daugirdas JT. Preventing and managing hypotension. Semin Dial. 1994; 7: 276–283
- Zager PG, Nikolic J, Brown RH, et al. “U” curve association of blood pressure and mortality in hemodialysis patients. Kidney Int. 1998; 54: 561–569
- Blowey DL, Balfe JW, Gupta I, Gajaria MM, Koren G. Midodrine efficacy and pharmacokinetics in a patient with recurrent intradialytic hypotension. Am J Kidney Dis. 1996; 28(1)132–136
- Flynn JJ, Mitchell MC, Caruso FS, McElligott MA. Midodrine treatment for patients with hemodialysis hypotension. Clin Nephrol. 1996; 45(4)261–267
- Lim PS, Yang CC, Li HP, Lim YT, Yeh CH. Midodrine for the treatment of intradialytic hypotension. Nephron. 1997; 77(3)279–283
- Cruz DN, Mahnensmith RL, Perazella MA. Intradialytic hypotension: Is midodrine beneficial in symptomatic hemodialysis patients?. Am J Kidney Dis. 1997; 30(6)772–779
- Cruz DN, Mahnensmith RL, Brickel HM, Perazella MA. Midodrine is effective and safe therapy for intradialytic hypotension over 8 months of follow-up. Clin Nephrol. 1998; 50(2)101–107
- Cruz DN, Mahnensmith RL, Brickel HM, Perazella MA. Midodrine and cool dialysate are effective therapies for symptomatic intradialytic hypotension. Am J Kidney Dis. 1999; 33(5)920–926
- Alappan R, Cruz D, Abu-Alfa AK, Mahnensmith R, Perazella MA. Treatment of severe intradialytic hypotension with the addition of high dialysate calcium concentration to midodrine and/or cool dialysate. Am J Kidney Dis. 2001; 37(2)294–299
- Hoeben H, Abu-Alfa AK, Mahnensmith R, Perazella MA. Hemodynamics in patients with intradialytic hypotension treated with cool dialysate or midodrine. Am J Kidney Dis. 2002; 39(1)102–107
- Fang JT, Huang CC. Midodrine hydrochloride in patients on hemodialysis with chronic hypotension. Ren Fail. 1996; 18(2)253–260
- Montagnac R, Clavel P, Delhotal-Landes B, Flouvat B, Poulain S, Schllinger F. Use of midodrine (Gutron) to treat permanent hypotension in a chronic hemodialysis patient. Clin Nephrol. 2001; 56(2)162–168
- Prakash S, Garg AX, Heidenheim P, House AA. Midodrine appears to be safe and effective for dialysis-induced hypotension: A systematic review. Nephrol Dial Transplant. 2004; 19: 2553–2558
- McTavish D, Goa KL. Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. Drugs. 1989; 38(5)757–777
- Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine vs. placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA. 1997; 277(13)1046–1051
- Jankovic J, Gilden JL, Hiner BC, et al. Neurogenic orthostatic hypotension: A double-blind, placebo-controlled study with midodrine. Am J Med. 1993; 95(1)38–48
- Stamatiadis DN, Gounari PA, Balitsari AV, Bokos JG, Stathakis CP. Hypotension on CAPD: Can use of vasoconstrictive drugs be harmful?. Perit Dial Int. 2002; 22(1)94–95